A Phase 1-2 Trial of DA-EPOCH-R Plus Ixazomib for MYC-aberrant Lymphoid Malignancies: the DACIPHOR Regimen.Reem Karmali,Carlos Galvez,Mehdi Hamadani,Leo Gordon,Jane Winter,Shuo Ma,Valerie Nelson,Timothy S. Fenske,Nirav N. Shah,Deepa Jagadeesh,Andreas Klein,Irene Helenowski,Ruohui Chen,Xinlei Mi,Adam Petrich,Andrew M. Evens,Barbara ProBLOOD ADVANCES(2024)引用 0|浏览61关键词Molecular ProfilingAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要